about
The bacterial preparation OK432 induces IL-12p70 secretion in human dendritic cells in a TLR3 dependent mannerImmunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyMaturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis.In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.Translating tumor antigens into cancer vaccinesIRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.Comparison between magnetic activated cell sorted monocytes and monocyte adherence techniques for in vitro generation of immature dendritic cells: an Egyptian trialInflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer.Immune cell recruitment and cell-based system for cancer therapy.Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigenAdvances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.Dendritic cell vaccination.Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.From cancer immunosurveillance to cancer immunotherapy.Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.Splenic CD11c(low)CD45RB(high) dendritic cells derived from endotoxin-tolerant mice attenuate experimental acute liver failure.Immunotherapy of distant metastatic disease.Aging and inflammation: etiological culprits of cancerAntigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approachesCD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection.MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Generation of immunogenic and tolerogenic clinical-grade dendritic cells.Exploiting dendritic cells in the development of cancer vaccines.Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model.Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects.A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology.Antigen-loaded ER microsomes from APC induce potent immune responses against viral infection.Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell.Tumour regression induced by co-administration of MIP-3α and CpG in an experimental model of colon carcinoma.Evaluation of an automated closed fluid management device for processing expanded cytokine-induced killer cells to use in immunotherapy programs for cancer.CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.Areca nut extracts suppress the differentiation and functionality of human monocyte-derived dendritic cells.Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.Breast cancer vaccination comes to age: impacts of bioinformatics
P2860
Q28480997-061CE460-EDA1-4A9F-A8A7-79844F57E99EQ33637584-4F966B22-B128-4027-9EAB-6991FB92ADB6Q33786246-029435FC-FC27-44D5-A438-749EF45963EDQ33886261-9D540243-E613-4C09-99D4-E2AB3294104BQ34382848-75006A1E-AFD0-4FE6-981C-F2E03CD2432FQ34484042-5C3AA50B-2D3C-4951-8AFE-17EC7F192DA7Q35156105-3B9D9EC2-EEA3-42BC-9F39-578DEE967BB9Q35756289-E249E2A5-DC7E-4535-9489-0C6859CDAD03Q36393268-2AA5D3A5-B673-4367-9AFB-D9C47E5E9280Q36485047-3DB82E9A-92F5-470F-A590-CA62C5230296Q36517706-D642B46A-20B0-4ED6-B81E-7BA7E55ED400Q36631270-97D5842E-3387-4F85-A973-4E71AFF9B79DQ36844954-676F4292-0FD1-45C5-8DC5-F6E7BB4C697EQ36899104-A7B6794A-D3B9-409D-9F1B-17F0B24527F1Q36959191-F328146E-4FED-4A50-A8B7-6568B3C1B48EQ36974722-0A362A52-EF46-49CF-B956-0C77959F3C8EQ36990588-2DEE949C-A7FB-4062-9330-49E7712605CFQ37099222-38DA815E-BA02-4127-8C42-B32CEE3CE4A1Q37254097-B11C9C8A-A399-437A-9274-7E5D331199E8Q37266668-C65507BE-5C2E-4FBD-BB22-70DC53ADEDBAQ37462069-1A66897B-F612-4D4C-A78D-F0DC11AF1857Q37470384-FE3543C7-2942-4C84-A9C5-15AF6B920B87Q37499721-02D19A1B-441C-449D-993E-361FF17D6395Q37613456-D60C6F23-B1E5-4562-8AB0-2336BFACBAD0Q37737313-AC69DC3C-FEBC-4ACE-B4F5-C224170CA1EBQ37945301-DDF10F6B-6EEA-4DAE-A27A-66ED2DF87234Q37959362-0FC42FC6-A182-4377-87BA-453B21644519Q38148774-0F2FB825-E722-41ED-9F0B-9E45EDFA3DAFQ38649472-441710DC-2E24-48AE-9D1D-913481D086B1Q39301153-77BE878E-323A-42A9-8605-1A1FF3746A96Q39408982-E7F77F64-078B-4B24-B8B9-87841285E3F7Q43112004-8C8CC2D2-7394-4818-ACB6-12C5D42CEC80Q43823714-4060D9F9-6D7E-437A-BE01-D61ABA7FCD22Q44379544-34C07CF0-9AF1-46B2-92C6-4616BCD4E727Q44828889-07640B6C-1E01-47B3-A007-FA9633371937Q46799061-3E74D91C-9118-4129-BAC4-0FA417A921F8Q48371221-AF874BEA-7176-40BC-B5D7-5BC7519EF1FAQ50270546-0EE08182-154E-4EF2-A35E-D1AA2ED27B29Q53251883-6A99EC04-ED36-48BA-ABB4-9327D231ED15Q57114951-BC482939-987B-4651-97F8-5EBC8958B1D9
P2860
description
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
Dendritic Cell-Based Immunotherapy
@en
Dendritic Cell-Based Immunotherapy
@nl
type
label
Dendritic Cell-Based Immunotherapy
@en
Dendritic Cell-Based Immunotherapy
@nl
prefLabel
Dendritic Cell-Based Immunotherapy
@en
Dendritic Cell-Based Immunotherapy
@nl
P2093
P2860
P1476
Dendritic cell-based immunotherapy
@en
P2093
Christopher Y Woo
Michael A Morse
Takuya Osada
Timothy M Clay
P2860
P304
P356
10.1080/08830180600992456
P577
2006-09-01T00:00:00Z